These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8714809)

  • 1. Psychotic episode related to phenylpropanolamine and amantadine in a healthy female.
    Stroe AE; Hall J; Amin F
    Gen Hosp Psychiatry; 1995 Nov; 17(6):457-8. PubMed ID: 8714809
    [No Abstract]   [Full Text] [Related]  

  • 2. Intense and recurrent déjà vu experiences related to amantadine and phenylpropanolamine in a healthy male.
    Taiminen T; Jääskeläinen SK
    J Clin Neurosci; 2001 Sep; 8(5):460-2. PubMed ID: 11535020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotic reaction caused by proprietary oral diet agents.
    Schaffer CB; Pauli MW
    Am J Psychiatry; 1980 Oct; 137(10):1256-7. PubMed ID: 7416278
    [No Abstract]   [Full Text] [Related]  

  • 4. [Phenylpropanolamine-induced psychoses].
    Widerlöv E
    Lakartidningen; 1979 Dec; 76(49):4529-30. PubMed ID: 544991
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenylpropanolamine anorexiants and affective disorders.
    Grigg JR; Goyer PF
    Mil Med; 1986 Jul; 151(7):387-8. PubMed ID: 3092141
    [No Abstract]   [Full Text] [Related]  

  • 6. Amantadine and alpha-methyldopa: effects and interactions.
    Cohen MR
    Am J Psychiatry; 1979 Jun; 136(6):864-5. PubMed ID: 443493
    [No Abstract]   [Full Text] [Related]  

  • 7. Exacerbation of psychosis by phenylpropanolamine.
    Goodhue A; Bartel RL; Smith NB
    Am J Psychiatry; 2000 Jun; 157(6):1021-2. PubMed ID: 10831490
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of affective psychosis after routine use of proprietary cold remedy containing phenylpropanolamine.
    Dewsnap P; Libby G
    Hum Exp Toxicol; 1992 Jul; 11(4):295-6. PubMed ID: 1354981
    [No Abstract]   [Full Text] [Related]  

  • 9. Amantadine-induced psychosis in a young healthy patient.
    Smith EJ
    Am J Psychiatry; 2008 Dec; 165(12):1613. PubMed ID: 19047338
    [No Abstract]   [Full Text] [Related]  

  • 10. Delirium with manic and psychotic features associated with amantadine.
    Neagoe AD
    Gen Hosp Psychiatry; 2013; 35(6):680.e7-8. PubMed ID: 23731892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine-like reactions to phenylpropanolamine.
    Dietz AJ
    JAMA; 1981 Feb; 245(6):601-2. PubMed ID: 7452888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paranoia in a polypharmacy setting.
    Cobbs LW
    Hosp Pract (Off Ed); 1992 Aug; 27(8):165-8. PubMed ID: 1644871
    [No Abstract]   [Full Text] [Related]  

  • 13. Amantadine-associated recurrence of psychosis.
    Hausner RS
    Am J Psychiatry; 1980 Feb; 137(2):240-2. PubMed ID: 7352586
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticholinergic syndrome with severe rhabdomyolysis--an unusual feature of amantadine toxicity.
    Yang CC; Deng JF
    Intensive Care Med; 1997 Mar; 23(3):355-6. PubMed ID: 9083247
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychotic episodes associated with the use of common proprietary decongestants.
    Kane FJ; Green BQ
    Am J Psychiatry; 1966 Oct; 123(4):484-7. PubMed ID: 4163280
    [No Abstract]   [Full Text] [Related]  

  • 16. Amantadine toxicity in a patient with renal insufficiency.
    Armbruster KF; Rahn AC; Ing TS; Halper IS; Oyama JH; Klawans HL
    Nephron; 1974; 13(2):183-6. PubMed ID: 4850491
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticholinergic psychosis in children: a case report.
    Hamdan-Allen G; Nixon M
    Hosp Community Psychiatry; 1991 Feb; 42(2):191-2. PubMed ID: 1997372
    [No Abstract]   [Full Text] [Related]  

  • 18. Amantadine-induced psychosis in a geriatric patient with renal disease.
    Borison RL
    Am J Psychiatry; 1979 Jan; 136(1):111-2. PubMed ID: 758814
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nil nocere. Adverse effects of amantadine therapy of parkinsonism. Summary to E.W. Fünfgeld: "Long-time therapy of parkinsonism with amantadine sulfate" and to G. Völler: "Amantadine therapy of parkinsonism"].
    Diehl LW
    Munch Med Wochenschr; 1972 Jun; 114(22):1068. PubMed ID: 5068023
    [No Abstract]   [Full Text] [Related]  

  • 20. [Amantadine therapy of Parkinson's syndrome. Comment on L.W. Diehl: "Nil nocere. Adverse effects of amantadine therapy of parkinsnism"].
    Völler G
    Munch Med Wochenschr; 1972 Jun; 114(22):1066-7. PubMed ID: 5068022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.